Vanoi fever
| This page (or section) is a work in progress by its author(s) and should not be considered final. |
| Vanoi fever | |
|---|---|
| Other names | Vanoi encephalitic fever, Vanoi hemorrhagic fever |
 | |
| Specialty | Infectious diseases |
| Symptoms | Fever, cough, dizziness |
| Complications | Meningitis, encephalitis, extreme aggression |
| Usual onset | 2–21 days after exposure |
| Causes | PC-60 |
| Risk factors | Direct contact with blood of infected people |
| Diagnostic method | Blood test |
| Treatment | Supportive care |
Vanoi fever, also known as Vanoi encephalitic fever (VEF) and Vanoi hemorrhagic fever (VHF) is a viral hemorrhagic fever caused by the PC-60 virus that affects most mammalian sapient species. Vanoi fever was first identified in the Vanoi Medical Center in Voskakova, Valokchia in May 2018, and caused the following Vanoi fever pandemic.
Symptoms usually begin from two days to three weeks after exposure and initially takes the form of influenza-like illness, followed by progressive inflammation of the meninges and central nervous system causing paranoia and insomnia before resulting in extreme aggression resembling furious rabies. Vanoi fever has a fatality rate of about 93% once it is allowed to progress to a late stage.
Vanoi fever is spread primarily through direct contact with body fluids, especially blood. There have been a handful of documented cases of Vanoi fever spreading through air, though airborne transmission of Vanoi fever remains rare.